person · Reporting owner

Auvil Paul R. III

Disclosed activity across 6 companies

Tapewire entity: 46965
SEC CIK: 0001410972

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
Cerebras Systems Inc.CBRS · Entity 3072	Director	May 15, 2026	May 15, 2026
Elastic N.V.ESTC · Entity 1064	Director	December 01, 2025	December 02, 2025
QUANTUM CORP /DE/QTM · Entity 4987	Director	September 01, 2017	September 05, 2017

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Cerebras Systems Inc.

Report date May 15, 2026 · Filed May 15, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Class A Common StockSEC Table I · non-derivative	Direct	0	Reported balance After 2026-05-15 transaction · row 1 1 source row Row 1 · 2026-05-15 · Other · Disposed 203,750 · Balance 0 F1: Immediately prior to the completion of the Issuer's initial public offering, each share of Class A common stock beneficially owned by the Reporting Person, including shares of Class A common stock underlying restricted stock unit ("RSU") and stock options awards, were reclassified into one share of Class B common stock in an exempt transaction pursuant to Rule 16b-7. Each share of Class B common stock is convertible at any time at the option of the holder into one share of Class A common stock.
Class B Common StockSEC Table II · derivative / convertible security	Direct	203,750	Reported balance After 2026-05-15 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2026-05-15 · Other · Acquired 203,750 · Balance 203,750 F1: Immediately prior to the completion of the Issuer's initial public offering, each share of Class A common stock beneficially owned by the Reporting Person, including shares of Class A common stock underlying restricted stock unit ("RSU") and stock options awards, were reclassified into one share of Class B common stock in an exempt transaction pursuant to Rule 16b-7. Each share of Class B common stock is convertible at any time at the option of the holder into one share of Class A common stock.

Filing footnotes · ownership attribution and instrument terms

F1: Immediately prior to the completion of the Issuer's initial public offering, each share of Class A common stock beneficially owned by the Reporting Person, including shares of Class A common stock underlying restricted stock unit ("RSU") and stock options awards, were reclassified into one share of Class B common stock in an exempt transaction pursuant to Rule 16b-7. Each share of Class B common stock is convertible at any time at the option of the holder into one share of Class A common stock.

Elastic N.V.

Report date December 01, 2025 · Filed December 02, 2025

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Ordinary SharesSEC Table I · non-derivative	Direct	37,956	Ending reported balance After 2025-12-01 transaction · row 3 3 source rows · reconciled sequence Row 1 · 2025-12-01 · Purchase · Acquired 1,000 · Balance 28,956 Row 2 · 2025-12-01 · Purchase · Acquired 5,000 · Balance 33,956 Row 3 · 2025-12-01 · Purchase · Acquired 4,000 · Balance 37,956

QUANTUM CORP /DE/

Report date September 01, 2017 · Filed September 05, 2017

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	101,735	Reported balance After 2017-09-01 transaction · row 1 Account or security details depend on footnotes; rows are not merged. 1 source row Row 1 · 2017-09-01 · Grant · Acquired 22,482 · Balance 101,735 F1: Restricted Stock Units will fully vest on the earlier to occur of: i) the date of Quantum Corporation's next Annual Stockholder Meeting; and ii) September 1, 2018. F2: The number of shares have been adjusted for the effect of the 1-for-8 reverse stock split effective April 18, 2017.

Filing footnotes · ownership attribution and instrument terms

F1: Restricted Stock Units will fully vest on the earlier to occur of: i) the date of Quantum Corporation's next Annual Stockholder Meeting; and ii) September 1, 2018.

F2: The number of shares have been adjusted for the effect of the 1-for-8 reverse stock split effective April 18, 2017.

Past disclosures · reporting ended (3)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

1Life Healthcare Inc

Report date February 22, 2023 · Filed February 24, 2023

Section 16 reporting ended · disclosed 2023-02-24. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosure context
Common StockSEC Table I · non-derivative	Direct	Reported balance After 2023-02-22 transaction · row 1 1 source row Row 1 · 2023-02-22 · Disposition to issuer · Disposed 12,586 · Balance 0 F1: Reflects disposition of Issuer common stock with the consummation of the transactions contemplated by the Agreement and Plan of Merger (the "Merger Agreement"), dated as of July 20, 2022, by and among Issuer, Amazon.com, Inc. ("Parent") and Negroni Merger Sub, Inc., a wholly owned subsidiary of Parent ("Merger Sub"), including the consummation of the merger (the "Merger") between Issuer and Merger Sub on February 22, 2023. Pursuant to the Merger Agreement, as of the effective time of the Merger (the "Effective Time"), each share of Issuer common stock, par value $0.001 per share ("Shares") issued and outstanding immediately prior to the Effective Time was converted automatically into the right to receive $18.00 in cash, without interest (the "Merger Consideration").
Stock Options (Right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $11.47 · Expires 2029-09-18	Direct	Reported balance After 2023-02-22 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2023-02-22 · Disposition to issuer · Disposed 10,462 · Balance 0 F2: Pursuant to the Merger Agreement, at the Effective Time, each outstanding option ("Option") to purchase Shares granted under any of the Issuer's 2007 Equity Incentive Plan, 2017 Equity Incentive Plan, 2020 Equity Incentive Plan and the Iora Third Amended and Restated 2011 Equity Incentive Plan (collective, the "Issuer Stock Plans") or portion thereof that was vested or became vested as of the Effective Time, and had an exercise price per Share that is less than the Merger Consideration, was canceled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the amount by which the Merger Consideration exceeds the applicable exercise price per Share of such Option and (ii) the aggregate number of Shares issuable upon exercise of such Option or portion thereof, subject to any required withholding of taxes. F3: The shares subject to the option vest as follows: 25% of the shares subject to the option vest on the first anniversary of the vesting commencement date; and 1/48th of the shares subject to the option vest monthly thereafter over the following three years, subject to reporting person's continuous service as of each such date. At the Effective Time, any unvested shares subject to the option were accelerated in full.
Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $20.55 · Expires 2030-04-14	Direct	Reported balance After 2023-02-22 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2023-02-22 · Disposition to issuer · Disposed 984 · Balance 0 F4: Pursuant to the Merger Agreement, at the Effective Time, each Option, whether vested or unvested, that has an exercise price per Share that is greater than the Merger Consideration was canceled without the payment of consideration. F5: The shares subject to the option are fully vested and immediately exercisable.
Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $29.00 · Expires 2030-05-13	Direct	Reported balance After 2023-02-22 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2023-02-22 · Disposition to issuer · Disposed 5,294 · Balance 0 F4: Pursuant to the Merger Agreement, at the Effective Time, each Option, whether vested or unvested, that has an exercise price per Share that is greater than the Merger Consideration was canceled without the payment of consideration. F5: The shares subject to the option are fully vested and immediately exercisable.
Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $40.55 · Expires 2030-07-14	Direct	Reported balance After 2023-02-22 transaction · row 5 Instrument identity requires review; Table II rows are not merged. 1 source row Row 5 · 2023-02-22 · Disposition to issuer · Disposed 498 · Balance 0 F4: Pursuant to the Merger Agreement, at the Effective Time, each Option, whether vested or unvested, that has an exercise price per Share that is greater than the Merger Consideration was canceled without the payment of consideration. F5: The shares subject to the option are fully vested and immediately exercisable.
Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $30.48 · Expires 2030-10-14	Direct	Reported balance After 2023-02-22 transaction · row 6 Instrument identity requires review; Table II rows are not merged. 1 source row Row 6 · 2023-02-22 · Disposition to issuer · Disposed 1,014 · Balance 0 F4: Pursuant to the Merger Agreement, at the Effective Time, each Option, whether vested or unvested, that has an exercise price per Share that is greater than the Merger Consideration was canceled without the payment of consideration. F5: The shares subject to the option are fully vested and immediately exercisable.
Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $42.68 · Expires 2031-01-14	Direct	Reported balance After 2023-02-22 transaction · row 7 Instrument identity requires review; Table II rows are not merged. 1 source row Row 7 · 2023-02-22 · Disposition to issuer · Disposed 725 · Balance 0 F4: Pursuant to the Merger Agreement, at the Effective Time, each Option, whether vested or unvested, that has an exercise price per Share that is greater than the Merger Consideration was canceled without the payment of consideration. F5: The shares subject to the option are fully vested and immediately exercisable.
Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $42.70 · Expires 2031-04-14	Direct	Reported balance After 2023-02-22 transaction · row 8 Instrument identity requires review; Table II rows are not merged. 1 source row Row 8 · 2023-02-22 · Disposition to issuer · Disposed 718 · Balance 0 F4: Pursuant to the Merger Agreement, at the Effective Time, each Option, whether vested or unvested, that has an exercise price per Share that is greater than the Merger Consideration was canceled without the payment of consideration. F5: The shares subject to the option are fully vested and immediately exercisable.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	Reported balance After 2023-02-22 transaction · row 9 Instrument identity requires review; Table II rows are not merged. 1 source row Row 9 · 2023-02-22 · Disposition to issuer · Disposed 20,728 · Balance 0 F6: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the issuer's common stock. RSUs convert into the issuer's common stock on a one-for-one basis. F7: The RSUs vest on the earlier of (i) the date of the issuer's next annual meeting of stockholders (or the date immediately prior to the next annual meeting of stockholders if the reporting person's service as a director ends at such meeting due to the director's failure to be re-elected or the director not standing for re-election); or (ii) the one-year anniversary measured from the date of grant. At the Effective Time, each outstanding RSU that was unvested was accelerated in full and was automatically converted in to the right to receive the Merger Consideration.

Filing footnotes · ownership attribution and instrument terms

F1: Reflects disposition of Issuer common stock with the consummation of the transactions contemplated by the Agreement and Plan of Merger (the "Merger Agreement"), dated as of July 20, 2022, by and among Issuer, Amazon.com, Inc. ("Parent") and Negroni Merger Sub, Inc., a wholly owned subsidiary of Parent ("Merger Sub"), including the consummation of the merger (the "Merger") between Issuer and Merger Sub on February 22, 2023. Pursuant to the Merger Agreement, as of the effective time of the Merger (the "Effective Time"), each share of Issuer common stock, par value $0.001 per share ("Shares") issued and outstanding immediately prior to the Effective Time was converted automatically into the right to receive $18.00 in cash, without interest (the "Merger Consideration").

F2: Pursuant to the Merger Agreement, at the Effective Time, each outstanding option ("Option") to purchase Shares granted under any of the Issuer's 2007 Equity Incentive Plan, 2017 Equity Incentive Plan, 2020 Equity Incentive Plan and the Iora Third Amended and Restated 2011 Equity Incentive Plan (collective, the "Issuer Stock Plans") or portion thereof that was vested or became vested as of the Effective Time, and had an exercise price per Share that is less than the Merger Consideration, was canceled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the amount by which the Merger Consideration exceeds the applicable exercise price per Share of such Option and (ii) the aggregate number of Shares issuable upon exercise of such Option or portion thereof, subject to any required withholding of taxes.

F3: The shares subject to the option vest as follows: 25% of the shares subject to the option vest on the first anniversary of the vesting commencement date; and 1/48th of the shares subject to the option vest monthly thereafter over the following three years, subject to reporting person's continuous service as of each such date. At the Effective Time, any unvested shares subject to the option were accelerated in full.

F4: Pursuant to the Merger Agreement, at the Effective Time, each Option, whether vested or unvested, that has an exercise price per Share that is greater than the Merger Consideration was canceled without the payment of consideration.

F5: The shares subject to the option are fully vested and immediately exercisable.

F6: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the issuer's common stock. RSUs convert into the issuer's common stock on a one-for-one basis.

F7: The RSUs vest on the earlier of (i) the date of the issuer's next annual meeting of stockholders (or the date immediately prior to the next annual meeting of stockholders if the reporting person's service as a director ends at such meeting due to the director's failure to be re-elected or the director not standing for re-election); or (ii) the one-year anniversary measured from the date of grant. At the Effective Time, each outstanding RSU that was unvested was accelerated in full and was automatically converted in to the right to receive the Merger Consideration.

MARIN SOFTWARE INC

Report date April 27, 2017 · Filed May 02, 2017

Section 16 reporting ended · disclosed 2017-05-02. Current position is not established by this disclosure.

No balance rows disclosed in this filing.

PROOFPOINT INC

Report date August 31, 2021 · Filed August 31, 2021

Section 16 reporting ended · disclosed 2021-08-31. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosure context
Common StockSEC Table I · non-derivative	Direct	Reported balance After 2021-08-31 transaction · row 1 1 source row Row 1 · 2021-08-31 · Disposition to issuer · Disposed 122,063 · Balance 0 F1: On April 25, 2021, Proofpoint, Inc. (the "Company") entered into an Agreement and Plan of Merger (as it may be amended, supplemented or otherwise modified from time to time, the "Merger Agreement") with Project Kafka Parent, LLC ("Parent") and Project Kafka Merger Sub, Inc., a wholly-owned subsidiary of Parent ("Merger Sub"), pursuant to which Merger Sub was merged with and into the Company (the "Merger"), with the Company surviving the Merger as a wholly owned subsidiary of Parent. Pursuant to the Merger Agreement, all shares of Company common stock outstanding immediately prior to the effective time of the Merger (the "Effective Time"), were canceled and converted automatically into the right to receive $176.00 in cash.
Common StockSEC Table I · non-derivative	IndirectBy family trust	Reported balance After 2021-08-31 transaction · row 2 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 2 · 2021-08-31 · Disposition to issuer · Disposed 261,918 · Balance 0 F1: On April 25, 2021, Proofpoint, Inc. (the "Company") entered into an Agreement and Plan of Merger (as it may be amended, supplemented or otherwise modified from time to time, the "Merger Agreement") with Project Kafka Parent, LLC ("Parent") and Project Kafka Merger Sub, Inc., a wholly-owned subsidiary of Parent ("Merger Sub"), pursuant to which Merger Sub was merged with and into the Company (the "Merger"), with the Company surviving the Merger as a wholly owned subsidiary of Parent. Pursuant to the Merger Agreement, all shares of Company common stock outstanding immediately prior to the effective time of the Merger (the "Effective Time"), were canceled and converted automatically into the right to receive $176.00 in cash.
Non-qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $36.00 · Expires 2024-03-26	Direct	Reported balance After 2021-08-31 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2021-08-31 · Disposition to issuer · Disposed 80,000 · Balance 0 F2: Pursuant to the Merger Agreement, at the Effective Time, each vested Company stock option was cancelled and converted into the right to receive an amount in cash equal to (i) the difference between $176.00 and the exercise price of such stock option multiplied by (ii) the number of shares subject to such stock option. F3: The stock option is fully vested.
Non-qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $57.49 · Expires 2025-04-06	Direct	Reported balance After 2021-08-31 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2021-08-31 · Disposition to issuer · Disposed 32,000 · Balance 0 F2: Pursuant to the Merger Agreement, at the Effective Time, each vested Company stock option was cancelled and converted into the right to receive an amount in cash equal to (i) the difference between $176.00 and the exercise price of such stock option multiplied by (ii) the number of shares subject to such stock option. F3: The stock option is fully vested.
Non-qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $50.93 · Expires 2026-04-08	Direct	Reported balance After 2021-08-31 transaction · row 5 Instrument identity requires review; Table II rows are not merged. 1 source row Row 5 · 2021-08-31 · Disposition to issuer · Disposed 32,000 · Balance 0 F2: Pursuant to the Merger Agreement, at the Effective Time, each vested Company stock option was cancelled and converted into the right to receive an amount in cash equal to (i) the difference between $176.00 and the exercise price of such stock option multiplied by (ii) the number of shares subject to such stock option. F3: The stock option is fully vested.
Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	Reported balance After 2021-08-31 transaction · row 6 Instrument identity requires review; Table II rows are not merged. 1 source row Row 6 · 2021-08-31 · Disposition to issuer · Disposed 4,150 · Balance 0 F4: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's common stock upon settlement for no consideration. F5: Pursuant to the Merger Agreement, immediately prior to the Effective Time, each unvested and outstanding restricted stock unit (each, an "Unvested Company RSU") was cancelled and converted into the right to receive an amount in cash equal to the product obtained by multiplying (x) the total number of shares of the Company's common stock underlying such Unvested Company RSU, by (y) $176.00, in each case subject to the same vesting schedule, termination terms and other conditions as such Unvested Company RSU was subject to immediately prior to the Effective Time, subject to the holder's continued service with the Parent or its affiliates. F6: Restricted stock units do not expire; they either vest or are canceled prior to vesting date.
Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	Reported balance After 2021-08-31 transaction · row 7 Instrument identity requires review; Table II rows are not merged. 1 source row Row 7 · 2021-08-31 · Disposition to issuer · Disposed 12,500 · Balance 0 F4: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's common stock upon settlement for no consideration. F5: Pursuant to the Merger Agreement, immediately prior to the Effective Time, each unvested and outstanding restricted stock unit (each, an "Unvested Company RSU") was cancelled and converted into the right to receive an amount in cash equal to the product obtained by multiplying (x) the total number of shares of the Company's common stock underlying such Unvested Company RSU, by (y) $176.00, in each case subject to the same vesting schedule, termination terms and other conditions as such Unvested Company RSU was subject to immediately prior to the Effective Time, subject to the holder's continued service with the Parent or its affiliates. F6: Restricted stock units do not expire; they either vest or are canceled prior to vesting date.
Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	Reported balance After 2021-08-31 transaction · row 8 Instrument identity requires review; Table II rows are not merged. 1 source row Row 8 · 2021-08-31 · Disposition to issuer · Disposed 8,000 · Balance 0 F4: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's common stock upon settlement for no consideration. F5: Pursuant to the Merger Agreement, immediately prior to the Effective Time, each unvested and outstanding restricted stock unit (each, an "Unvested Company RSU") was cancelled and converted into the right to receive an amount in cash equal to the product obtained by multiplying (x) the total number of shares of the Company's common stock underlying such Unvested Company RSU, by (y) $176.00, in each case subject to the same vesting schedule, termination terms and other conditions as such Unvested Company RSU was subject to immediately prior to the Effective Time, subject to the holder's continued service with the Parent or its affiliates. F6: Restricted stock units do not expire; they either vest or are canceled prior to vesting date.
Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	Reported balance After 2021-08-31 transaction · row 9 Instrument identity requires review; Table II rows are not merged. 1 source row Row 9 · 2021-08-31 · Disposition to issuer · Disposed 11,250 · Balance 0 F4: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's common stock upon settlement for no consideration. F5: Pursuant to the Merger Agreement, immediately prior to the Effective Time, each unvested and outstanding restricted stock unit (each, an "Unvested Company RSU") was cancelled and converted into the right to receive an amount in cash equal to the product obtained by multiplying (x) the total number of shares of the Company's common stock underlying such Unvested Company RSU, by (y) $176.00, in each case subject to the same vesting schedule, termination terms and other conditions as such Unvested Company RSU was subject to immediately prior to the Effective Time, subject to the holder's continued service with the Parent or its affiliates. F6: Restricted stock units do not expire; they either vest or are canceled prior to vesting date.
Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	Reported balance After 2021-08-31 transaction · row 10 Instrument identity requires review; Table II rows are not merged. 1 source row Row 10 · 2021-08-31 · Disposition to issuer · Disposed 40,000 · Balance 0 F4: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's common stock upon settlement for no consideration. F5: Pursuant to the Merger Agreement, immediately prior to the Effective Time, each unvested and outstanding restricted stock unit (each, an "Unvested Company RSU") was cancelled and converted into the right to receive an amount in cash equal to the product obtained by multiplying (x) the total number of shares of the Company's common stock underlying such Unvested Company RSU, by (y) $176.00, in each case subject to the same vesting schedule, termination terms and other conditions as such Unvested Company RSU was subject to immediately prior to the Effective Time, subject to the holder's continued service with the Parent or its affiliates. F6: Restricted stock units do not expire; they either vest or are canceled prior to vesting date.
Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	Reported balance After 2021-08-31 transaction · row 11 Instrument identity requires review; Table II rows are not merged. 1 source row Row 11 · 2021-08-31 · Disposition to issuer · Disposed 2,812 · Balance 0 F4: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's common stock upon settlement for no consideration. F5: Pursuant to the Merger Agreement, immediately prior to the Effective Time, each unvested and outstanding restricted stock unit (each, an "Unvested Company RSU") was cancelled and converted into the right to receive an amount in cash equal to the product obtained by multiplying (x) the total number of shares of the Company's common stock underlying such Unvested Company RSU, by (y) $176.00, in each case subject to the same vesting schedule, termination terms and other conditions as such Unvested Company RSU was subject to immediately prior to the Effective Time, subject to the holder's continued service with the Parent or its affiliates. F6: Restricted stock units do not expire; they either vest or are canceled prior to vesting date. F7: The restricted stock units were earned by the Reporting Person on April 20, 2021 as determined by the Issuer's Board of Directors.

Filing footnotes · ownership attribution and instrument terms

F1: On April 25, 2021, Proofpoint, Inc. (the "Company") entered into an Agreement and Plan of Merger (as it may be amended, supplemented or otherwise modified from time to time, the "Merger Agreement") with Project Kafka Parent, LLC ("Parent") and Project Kafka Merger Sub, Inc., a wholly-owned subsidiary of Parent ("Merger Sub"), pursuant to which Merger Sub was merged with and into the Company (the "Merger"), with the Company surviving the Merger as a wholly owned subsidiary of Parent. Pursuant to the Merger Agreement, all shares of Company common stock outstanding immediately prior to the effective time of the Merger (the "Effective Time"), were canceled and converted automatically into the right to receive $176.00 in cash.

F2: Pursuant to the Merger Agreement, at the Effective Time, each vested Company stock option was cancelled and converted into the right to receive an amount in cash equal to (i) the difference between $176.00 and the exercise price of such stock option multiplied by (ii) the number of shares subject to such stock option.

F3: The stock option is fully vested.

F4: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's common stock upon settlement for no consideration.

F5: Pursuant to the Merger Agreement, immediately prior to the Effective Time, each unvested and outstanding restricted stock unit (each, an "Unvested Company RSU") was cancelled and converted into the right to receive an amount in cash equal to the product obtained by multiplying (x) the total number of shares of the Company's common stock underlying such Unvested Company RSU, by (y) $176.00, in each case subject to the same vesting schedule, termination terms and other conditions as such Unvested Company RSU was subject to immediately prior to the Effective Time, subject to the holder's continued service with the Parent or its affiliates.

F6: Restricted stock units do not expire; they either vest or are canceled prior to vesting date.

F7: The restricted stock units were earned by the Reporting Person on April 20, 2021 as determined by the Issuer's Board of Directors.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
May 15, 2026 Filed May 15, 2026 22:49 UTC	Cerebras Systems Inc. CBRS · Entity 3072	OtherClass B Common Stock · Derivative	203,750	Not disclosed	Not disclosed	Disclosure SEC source: 0001628280-26-035741 · wk-form4_1778885396.xml · derivative · entry 2 Auvil Paul R. III · CIK 0001410972 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 203,750 Underlying: Class A Common Stock · 203,750 shares Expires not disclosed F1 · derivative.exercise_price: Immediately prior to the completion of the Issuer's initial public offering, each share of Class A common stock beneficially owned by the Reporting Person, including shares of Class A common stock underlying restricted stock unit ("RSU") and stock options awards, were reclassified into one share of Class B common stock in an exempt transaction pursuant to Rule 16b-7. Each share of Class B common stock is convertible at any time at the option of the holder into one share of Class A common stock. F1 · kind: Immediately prior to the completion of the Issuer's initial public offering, each share of Class A common stock beneficially owned by the Reporting Person, including shares of Class A common stock underlying restricted stock unit ("RSU") and stock options awards, were reclassified into one share of Class B common stock in an exempt transaction pursuant to Rule 16b-7. Each share of Class B common stock is convertible at any time at the option of the holder into one share of Class A common stock. F1 · price: Immediately prior to the completion of the Issuer's initial public offering, each share of Class A common stock beneficially owned by the Reporting Person, including shares of Class A common stock underlying restricted stock unit ("RSU") and stock options awards, were reclassified into one share of Class B common stock in an exempt transaction pursuant to Rule 16b-7. Each share of Class B common stock is convertible at any time at the option of the holder into one share of Class A common stock. F1 · derivative.exercise_date: Immediately prior to the completion of the Issuer's initial public offering, each share of Class A common stock beneficially owned by the Reporting Person, including shares of Class A common stock underlying restricted stock unit ("RSU") and stock options awards, were reclassified into one share of Class B common stock in an exempt transaction pursuant to Rule 16b-7. Each share of Class B common stock is convertible at any time at the option of the holder into one share of Class A common stock. F1 · derivative.expiration_date: Immediately prior to the completion of the Issuer's initial public offering, each share of Class A common stock beneficially owned by the Reporting Person, including shares of Class A common stock underlying restricted stock unit ("RSU") and stock options awards, were reclassified into one share of Class B common stock in an exempt transaction pursuant to Rule 16b-7. Each share of Class B common stock is convertible at any time at the option of the holder into one share of Class A common stock. Read SEC document
May 15, 2026 Filed May 15, 2026 22:49 UTC	Cerebras Systems Inc. CBRS · Entity 3072	OtherClass A Common Stock	203,750	Not disclosed	Not disclosed	Disclosure SEC source: 0001628280-26-035741 · wk-form4_1778885396.xml · nonDerivative · entry 1 Auvil Paul R. III · CIK 0001410972 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · kind: Immediately prior to the completion of the Issuer's initial public offering, each share of Class A common stock beneficially owned by the Reporting Person, including shares of Class A common stock underlying restricted stock unit ("RSU") and stock options awards, were reclassified into one share of Class B common stock in an exempt transaction pursuant to Rule 16b-7. Each share of Class B common stock is convertible at any time at the option of the holder into one share of Class A common stock. F1 · price: Immediately prior to the completion of the Issuer's initial public offering, each share of Class A common stock beneficially owned by the Reporting Person, including shares of Class A common stock underlying restricted stock unit ("RSU") and stock options awards, were reclassified into one share of Class B common stock in an exempt transaction pursuant to Rule 16b-7. Each share of Class B common stock is convertible at any time at the option of the holder into one share of Class A common stock. Read SEC document
December 01, 2025 Filed Dec 2, 2025 21:39 UTC	Elastic N.V. ESTC · Entity 1064	PurchaseOrdinary Shares	4,000	$71.04	$284,160.00	Disclosure SEC source: 0001123292-25-000679 · form4.xml · nonDerivative · entry 3 Auvil Paul R. III · CIK 0001410972 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,956 Read SEC document
December 01, 2025 Filed Dec 2, 2025 21:39 UTC	Elastic N.V. ESTC · Entity 1064	PurchaseOrdinary Shares	5,000	$71.01	$355,050.00	Disclosure SEC source: 0001123292-25-000679 · form4.xml · nonDerivative · entry 2 Auvil Paul R. III · CIK 0001410972 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,956 Read SEC document
December 01, 2025 Filed Dec 2, 2025 21:39 UTC	Elastic N.V. ESTC · Entity 1064	PurchaseOrdinary Shares	1,000	$71.02	$71,020.00	Disclosure SEC source: 0001123292-25-000679 · form4.xml · nonDerivative · entry 1 Auvil Paul R. III · CIK 0001410972 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,956 Read SEC document
September 30, 2025 Filed Oct 2, 2025 22:02 UTC	Elastic N.V. ESTC · Entity 1064	GrantOrdinary Shares	2,663	$0.00	$0.00	Disclosure SEC source: 0001123292-25-000504 · form4.xml · nonDerivative · entry 1 Auvil Paul R. III · CIK 0001410972 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,956 F1 · shares: Represents restricted stock units that vest in full on the earlier of (i) the day prior to the date of the Issuer's next annual general meeting of shareholders or (ii) September 30, 2026. Read SEC document
October 01, 2024 Filed Oct 2, 2024 22:47 UTC	Elastic N.V. ESTC · Entity 1064	GrantOrdinary Shares	2,666	$0.00	$0.00	Disclosure SEC source: 0001062993-24-017326 · form4.xml · nonDerivative · entry 1 Auvil Paul R. III · CIK 0001410972 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,293 F1 · shares: Represents restricted stock units that vest in full on the earlier of (i) the day prior to the date of the Issuer's next annual general meeting of shareholders or (ii) September 29, 2025. Read SEC document
September 03, 2024 Filed Sep 3, 2024 20:50 UTC	Elastic N.V. ESTC · Entity 1064	PurchaseOrdinary Shares	20,000	$74.25	$1,484,968.00	Disclosure SEC source: 0001062993-24-016006 · form4.xml · nonDerivative · entry 1 Auvil Paul R. III · CIK 0001410972 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,627 Read SEC document
October 05, 2023 Filed Oct 10, 2023 21:03 UTC	Elastic N.V. ESTC · Entity 1064	GrantOrdinary Shares	2,627	$0.00	$0.00	Disclosure SEC source: 0001062993-23-019202 · form4.xml · nonDerivative · entry 1 Auvil Paul R. III · CIK 0001410972 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,627 F1 · shares: Represents restricted stock units that vest in full on the earlier of (i) the day prior to the date of the Issuer's next annual general meeting of shareholders or (ii) October 5, 2024. Read SEC document
February 22, 2023 Filed Feb 24, 2023 22:27 UTC	1Life Healthcare Inc ONEM · Entity 116460	Disposition to issuerRestricted Stock Units · Derivative	20,728	Not disclosed	Not disclosed	Disclosure SEC source: 0001562180-23-001845 · primarydocument.xml · derivative · entry 9 Auvil Paul R. III · CIK 0001410972 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,728 shares Expires not disclosed F6 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the issuer's common stock. RSUs convert into the issuer's common stock on a one-for-one basis. F7 · price: The RSUs vest on the earlier of (i) the date of the issuer's next annual meeting of stockholders (or the date immediately prior to the next annual meeting of stockholders if the reporting person's service as a director ends at such meeting due to the director's failure to be re-elected or the director not standing for re-election); or (ii) the one-year anniversary measured from the date of grant. At the Effective Time, each outstanding RSU that was unvested was accelerated in full and was automatically converted in to the right to receive the Merger Consideration. F7 · derivative.exercise_date: The RSUs vest on the earlier of (i) the date of the issuer's next annual meeting of stockholders (or the date immediately prior to the next annual meeting of stockholders if the reporting person's service as a director ends at such meeting due to the director's failure to be re-elected or the director not standing for re-election); or (ii) the one-year anniversary measured from the date of grant. At the Effective Time, each outstanding RSU that was unvested was accelerated in full and was automatically converted in to the right to receive the Merger Consideration. F7 · derivative.expiration_date: The RSUs vest on the earlier of (i) the date of the issuer's next annual meeting of stockholders (or the date immediately prior to the next annual meeting of stockholders if the reporting person's service as a director ends at such meeting due to the director's failure to be re-elected or the director not standing for re-election); or (ii) the one-year anniversary measured from the date of grant. At the Effective Time, each outstanding RSU that was unvested was accelerated in full and was automatically converted in to the right to receive the Merger Consideration. Read SEC document
February 22, 2023 Filed Feb 24, 2023 22:27 UTC	1Life Healthcare Inc ONEM · Entity 116460	Disposition to issuerStock Option (Right to Buy) · Derivative	718	Not disclosed Strike: $42.70	Not disclosed	Disclosure SEC source: 0001562180-23-001845 · primarydocument.xml · derivative · entry 8 Auvil Paul R. III · CIK 0001410972 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 718 shares Expires 2031-04-14 F4 · price: Pursuant to the Merger Agreement, at the Effective Time, each Option, whether vested or unvested, that has an exercise price per Share that is greater than the Merger Consideration was canceled without the payment of consideration. F5 · derivative.exercise_date: The shares subject to the option are fully vested and immediately exercisable. Read SEC document
February 22, 2023 Filed Feb 24, 2023 22:27 UTC	1Life Healthcare Inc ONEM · Entity 116460	Disposition to issuerStock Option (Right to Buy) · Derivative	725	Not disclosed Strike: $42.68	Not disclosed	Disclosure SEC source: 0001562180-23-001845 · primarydocument.xml · derivative · entry 7 Auvil Paul R. III · CIK 0001410972 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 725 shares Expires 2031-01-14 F4 · price: Pursuant to the Merger Agreement, at the Effective Time, each Option, whether vested or unvested, that has an exercise price per Share that is greater than the Merger Consideration was canceled without the payment of consideration. F5 · derivative.exercise_date: The shares subject to the option are fully vested and immediately exercisable. Read SEC document
February 22, 2023 Filed Feb 24, 2023 22:27 UTC	1Life Healthcare Inc ONEM · Entity 116460	Disposition to issuerStock Option (Right to Buy) · Derivative	1,014	Not disclosed Strike: $30.48	Not disclosed	Disclosure SEC source: 0001562180-23-001845 · primarydocument.xml · derivative · entry 6 Auvil Paul R. III · CIK 0001410972 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,014 shares Expires 2030-10-14 F4 · price: Pursuant to the Merger Agreement, at the Effective Time, each Option, whether vested or unvested, that has an exercise price per Share that is greater than the Merger Consideration was canceled without the payment of consideration. F5 · derivative.exercise_date: The shares subject to the option are fully vested and immediately exercisable. Read SEC document
February 22, 2023 Filed Feb 24, 2023 22:27 UTC	1Life Healthcare Inc ONEM · Entity 116460	Disposition to issuerStock Option (Right to Buy) · Derivative	498	Not disclosed Strike: $40.55	Not disclosed	Disclosure SEC source: 0001562180-23-001845 · primarydocument.xml · derivative · entry 5 Auvil Paul R. III · CIK 0001410972 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 498 shares Expires 2030-07-14 F4 · price: Pursuant to the Merger Agreement, at the Effective Time, each Option, whether vested or unvested, that has an exercise price per Share that is greater than the Merger Consideration was canceled without the payment of consideration. F5 · derivative.exercise_date: The shares subject to the option are fully vested and immediately exercisable. Read SEC document
February 22, 2023 Filed Feb 24, 2023 22:27 UTC	1Life Healthcare Inc ONEM · Entity 116460	Disposition to issuerStock Option (Right to Buy) · Derivative	5,294	Not disclosed Strike: $29.00	Not disclosed	Disclosure SEC source: 0001562180-23-001845 · primarydocument.xml · derivative · entry 4 Auvil Paul R. III · CIK 0001410972 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,294 shares Expires 2030-05-13 F4 · price: Pursuant to the Merger Agreement, at the Effective Time, each Option, whether vested or unvested, that has an exercise price per Share that is greater than the Merger Consideration was canceled without the payment of consideration. F5 · derivative.exercise_date: The shares subject to the option are fully vested and immediately exercisable. Read SEC document
February 22, 2023 Filed Feb 24, 2023 22:27 UTC	1Life Healthcare Inc ONEM · Entity 116460	Disposition to issuerStock Option (Right to Buy) · Derivative	984	Not disclosed Strike: $20.55	Not disclosed	Disclosure SEC source: 0001562180-23-001845 · primarydocument.xml · derivative · entry 3 Auvil Paul R. III · CIK 0001410972 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 984 shares Expires 2030-04-14 F4 · price: Pursuant to the Merger Agreement, at the Effective Time, each Option, whether vested or unvested, that has an exercise price per Share that is greater than the Merger Consideration was canceled without the payment of consideration. F5 · derivative.exercise_date: The shares subject to the option are fully vested and immediately exercisable. Read SEC document
February 22, 2023 Filed Feb 24, 2023 22:27 UTC	1Life Healthcare Inc ONEM · Entity 116460	Disposition to issuerStock Options (Right to buy) · Derivative	10,462	Not disclosed Strike: $11.47	Not disclosed	Disclosure SEC source: 0001562180-23-001845 · primarydocument.xml · derivative · entry 2 Auvil Paul R. III · CIK 0001410972 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,462 shares Expires 2029-09-18 F2 · price: Pursuant to the Merger Agreement, at the Effective Time, each outstanding option ("Option") to purchase Shares granted under any of the Issuer's 2007 Equity Incentive Plan, 2017 Equity Incentive Plan, 2020 Equity Incentive Plan and the Iora Third Amended and Restated 2011 Equity Incentive Plan (collective, the "Issuer Stock Plans") or portion thereof that was vested or became vested as of the Effective Time, and had an exercise price per Share that is less than the Merger Consideration, was canceled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the amount by which the Merger Consideration exceeds the applicable exercise price per Share of such Option and (ii) the aggregate number of Shares issuable upon exercise of such Option or portion thereof, subject to any required withholding of taxes. F3 · derivative.exercise_date: The shares subject to the option vest as follows: 25% of the shares subject to the option vest on the first anniversary of the vesting commencement date; and 1/48th of the shares subject to the option vest monthly thereafter over the following three years, subject to reporting person's continuous service as of each such date. At the Effective Time, any unvested shares subject to the option were accelerated in full. Read SEC document
February 22, 2023 Filed Feb 24, 2023 22:27 UTC	1Life Healthcare Inc ONEM · Entity 116460	Disposition to issuerCommon Stock	12,586	$18.00	$226,548.00	Disclosure SEC source: 0001562180-23-001845 · primarydocument.xml · nonDerivative · entry 1 Auvil Paul R. III · CIK 0001410972 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Reflects disposition of Issuer common stock with the consummation of the transactions contemplated by the Agreement and Plan of Merger (the "Merger Agreement"), dated as of July 20, 2022, by and among Issuer, Amazon.com, Inc. ("Parent") and Negroni Merger Sub, Inc., a wholly owned subsidiary of Parent ("Merger Sub"), including the consummation of the merger (the "Merger") between Issuer and Merger Sub on February 22, 2023. Pursuant to the Merger Agreement, as of the effective time of the Merger (the "Effective Time"), each share of Issuer common stock, par value $0.001 per share ("Shares") issued and outstanding immediately prior to the Effective Time was converted automatically into the right to receive $18.00 in cash, without interest (the "Merger Consideration"). Read SEC document
January 15, 2023 Filed Jan 18, 2023 23:39 UTC	1Life Healthcare Inc ONEM · Entity 116460	GrantCommon Stock	1,051	$0.00	$0.00	Disclosure SEC source: 0001562180-23-000488 · primarydocument.xml · nonDerivative · entry 1 Auvil Paul R. III · CIK 0001410972 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,586 F1 · shares: Represents restricted stock units granted to the reporting person pursuant to the Issuer's 2020 Equity Incentive Plan. The restricted stock units vested immediately on the date of grant. Read SEC document
October 15, 2022 Filed Oct 18, 2022 23:36 UTC	1Life Healthcare Inc ONEM · Entity 116460	GrantCommon Stock	1,023	$0.00	$0.00	Disclosure SEC source: 0001562180-22-007257 · primarydocument.xml · nonDerivative · entry 1 Auvil Paul R. III · CIK 0001410972 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,535 F1 · shares: Represents restricted stock units granted to the reporting person pursuant to the Issuer's 2020 Equity Incentive Plan. The restricted stock units vested immediately on the date of grant. Read SEC document
July 15, 2022 Filed Jul 19, 2022 20:49 UTC	1Life Healthcare Inc ONEM · Entity 116460	GrantCommon Stock	1,916	$0.00	$0.00	Disclosure SEC source: 0001562180-22-005716 · primarydocument.xml · nonDerivative · entry 1 Auvil Paul R. III · CIK 0001410972 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,512 F1 · shares: Represents restricted stock units granted to the reporting person pursuant to the Issuer's 2020 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units vested immediately on the date of grant. Read SEC document
June 02, 2022 Filed Jun 7, 2022 00:39 UTC	1Life Healthcare Inc ONEM · Entity 116460	GrantRestricted Stock Units · Derivative	20,728	$0.00	$0.00	Disclosure SEC source: 0001562180-22-004855 · primarydocument.xml · derivative · entry 3 Auvil Paul R. III · CIK 0001410972 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,728 Underlying: Common Stock · 20,728 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Restricted stock units convert into the issuer's common stock on a one-for-one basis. F2 · derivative.exercise_date: The restricted stock units vest on the earlier of (i) the date of the issuer's next annual meeting of stockholders (or the date immediately prior to the next annual meeting of stockholders if the reporting person's service as a director ends at such meeting due to the director's failure to be re-elected or the director not standing for re-election); or (ii) the one-year anniversary measured from the date of grant. F2 · derivative.expiration_date: The restricted stock units vest on the earlier of (i) the date of the issuer's next annual meeting of stockholders (or the date immediately prior to the next annual meeting of stockholders if the reporting person's service as a director ends at such meeting due to the director's failure to be re-elected or the director not standing for re-election); or (ii) the one-year anniversary measured from the date of grant. Read SEC document
June 02, 2022 Filed Jun 7, 2022 00:39 UTC	1Life Healthcare Inc ONEM · Entity 116460	Exercise / conversionRestricted Stock Units · Derivative	4,534	$0.00	$0.00	Disclosure SEC source: 0001562180-22-004855 · primarydocument.xml · derivative · entry 2 Auvil Paul R. III · CIK 0001410972 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,534 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Restricted stock units convert into the issuer's common stock on a one-for-one basis. F2 · derivative.exercise_date: The restricted stock units vest on the earlier of (i) the date of the issuer's next annual meeting of stockholders (or the date immediately prior to the next annual meeting of stockholders if the reporting person's service as a director ends at such meeting due to the director's failure to be re-elected or the director not standing for re-election); or (ii) the one-year anniversary measured from the date of grant. F2 · derivative.expiration_date: The restricted stock units vest on the earlier of (i) the date of the issuer's next annual meeting of stockholders (or the date immediately prior to the next annual meeting of stockholders if the reporting person's service as a director ends at such meeting due to the director's failure to be re-elected or the director not standing for re-election); or (ii) the one-year anniversary measured from the date of grant. Read SEC document
June 02, 2022 Filed Jun 7, 2022 00:39 UTC	1Life Healthcare Inc ONEM · Entity 116460	Exercise / conversionCommon Stock	4,534	Not disclosed	Not disclosed	Disclosure SEC source: 0001562180-22-004855 · primarydocument.xml · nonDerivative · entry 1 Auvil Paul R. III · CIK 0001410972 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,596 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Restricted stock units convert into the issuer's common stock on a one-for-one basis. Read SEC document
April 15, 2022 Filed Apr 19, 2022 20:53 UTC	1Life Healthcare Inc ONEM · Entity 116460	GrantCommon Stock	1,643	$0.00	$0.00	Disclosure SEC source: 0001562180-22-003465 · primarydocument.xml · nonDerivative · entry 1 Auvil Paul R. III · CIK 0001410972 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,062 F1 · shares: Represents restricted stock units granted to the reporting person pursuant to the Issuer's 2020 Equity Incentive Plan. The restricted stock units vested immediately on the date of grant. Read SEC document
January 15, 2022 Filed Jan 20, 2022 01:29 UTC	1Life Healthcare Inc ONEM · Entity 116460	GrantCommon Stock	1,075	$0.00	$0.00	Disclosure SEC source: 0001562180-22-000535 · primarydocument.xml · nonDerivative · entry 1 Auvil Paul R. III · CIK 0001410972 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,419 F1 · shares: Represents restricted stock units granted to the reporting person pursuant to the Issuer's 2020 Equity Incentive Plan. The restricted stock units vested immediately on the date of grant. Read SEC document
October 15, 2021 Filed Oct 19, 2021 23:33 UTC	1Life Healthcare Inc ONEM · Entity 116460	GrantCommon Stock	810	$0.00	$0.00	Disclosure SEC source: 0001562180-21-006572 · primarydocument.xml · nonDerivative · entry 1 Auvil Paul R. III · CIK 0001410972 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,344 F1 · shares: Represents restricted stock units granted to the reporting person pursuant to the Issuer's 2020 Equity Incentive Plan. The restricted stock units vested immediately on the date of grant. Read SEC document
August 31, 2021 Filed Aug 31, 2021 18:02 UTC	PROOFPOINT INC PFPT · Entity 135877	Disposition to issuerRestricted Stock Units · Derivative	2,812	Not disclosed Strike: $0.00	Not disclosed	Disclosure SEC source: 0001209191-21-054026 · doc4.xml · derivative · entry 11 Auvil Paul R. III · CIK 0001410972 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,812 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's common stock upon settlement for no consideration. F5 · kind: Pursuant to the Merger Agreement, immediately prior to the Effective Time, each unvested and outstanding restricted stock unit (each, an "Unvested Company RSU") was cancelled and converted into the right to receive an amount in cash equal to the product obtained by multiplying (x) the total number of shares of the Company's common stock underlying such Unvested Company RSU, by (y) $176.00, in each case subject to the same vesting schedule, termination terms and other conditions as such Unvested Company RSU was subject to immediately prior to the Effective Time, subject to the holder's continued service with the Parent or its affiliates. F5 · price: Pursuant to the Merger Agreement, immediately prior to the Effective Time, each unvested and outstanding restricted stock unit (each, an "Unvested Company RSU") was cancelled and converted into the right to receive an amount in cash equal to the product obtained by multiplying (x) the total number of shares of the Company's common stock underlying such Unvested Company RSU, by (y) $176.00, in each case subject to the same vesting schedule, termination terms and other conditions as such Unvested Company RSU was subject to immediately prior to the Effective Time, subject to the holder's continued service with the Parent or its affiliates. F5 · derivative.exercise_date: Pursuant to the Merger Agreement, immediately prior to the Effective Time, each unvested and outstanding restricted stock unit (each, an "Unvested Company RSU") was cancelled and converted into the right to receive an amount in cash equal to the product obtained by multiplying (x) the total number of shares of the Company's common stock underlying such Unvested Company RSU, by (y) $176.00, in each case subject to the same vesting schedule, termination terms and other conditions as such Unvested Company RSU was subject to immediately prior to the Effective Time, subject to the holder's continued service with the Parent or its affiliates. F6 · derivative.expiration_date: Restricted stock units do not expire; they either vest or are canceled prior to vesting date. F7 · derivative.underlying_shares: The restricted stock units were earned by the Reporting Person on April 20, 2021 as determined by the Issuer's Board of Directors. Read SEC document
August 31, 2021 Filed Aug 31, 2021 18:02 UTC	PROOFPOINT INC PFPT · Entity 135877	Disposition to issuerRestricted Stock Units · Derivative	40,000	Not disclosed Strike: $0.00	Not disclosed	Disclosure SEC source: 0001209191-21-054026 · doc4.xml · derivative · entry 10 Auvil Paul R. III · CIK 0001410972 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 40,000 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's common stock upon settlement for no consideration. F5 · kind: Pursuant to the Merger Agreement, immediately prior to the Effective Time, each unvested and outstanding restricted stock unit (each, an "Unvested Company RSU") was cancelled and converted into the right to receive an amount in cash equal to the product obtained by multiplying (x) the total number of shares of the Company's common stock underlying such Unvested Company RSU, by (y) $176.00, in each case subject to the same vesting schedule, termination terms and other conditions as such Unvested Company RSU was subject to immediately prior to the Effective Time, subject to the holder's continued service with the Parent or its affiliates. F5 · price: Pursuant to the Merger Agreement, immediately prior to the Effective Time, each unvested and outstanding restricted stock unit (each, an "Unvested Company RSU") was cancelled and converted into the right to receive an amount in cash equal to the product obtained by multiplying (x) the total number of shares of the Company's common stock underlying such Unvested Company RSU, by (y) $176.00, in each case subject to the same vesting schedule, termination terms and other conditions as such Unvested Company RSU was subject to immediately prior to the Effective Time, subject to the holder's continued service with the Parent or its affiliates. F5 · derivative.exercise_date: Pursuant to the Merger Agreement, immediately prior to the Effective Time, each unvested and outstanding restricted stock unit (each, an "Unvested Company RSU") was cancelled and converted into the right to receive an amount in cash equal to the product obtained by multiplying (x) the total number of shares of the Company's common stock underlying such Unvested Company RSU, by (y) $176.00, in each case subject to the same vesting schedule, termination terms and other conditions as such Unvested Company RSU was subject to immediately prior to the Effective Time, subject to the holder's continued service with the Parent or its affiliates. F6 · derivative.expiration_date: Restricted stock units do not expire; they either vest or are canceled prior to vesting date. Read SEC document
August 31, 2021 Filed Aug 31, 2021 18:02 UTC	PROOFPOINT INC PFPT · Entity 135877	Disposition to issuerRestricted Stock Units · Derivative	11,250	Not disclosed Strike: $0.00	Not disclosed	Disclosure SEC source: 0001209191-21-054026 · doc4.xml · derivative · entry 9 Auvil Paul R. III · CIK 0001410972 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,250 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's common stock upon settlement for no consideration. F5 · kind: Pursuant to the Merger Agreement, immediately prior to the Effective Time, each unvested and outstanding restricted stock unit (each, an "Unvested Company RSU") was cancelled and converted into the right to receive an amount in cash equal to the product obtained by multiplying (x) the total number of shares of the Company's common stock underlying such Unvested Company RSU, by (y) $176.00, in each case subject to the same vesting schedule, termination terms and other conditions as such Unvested Company RSU was subject to immediately prior to the Effective Time, subject to the holder's continued service with the Parent or its affiliates. F5 · price: Pursuant to the Merger Agreement, immediately prior to the Effective Time, each unvested and outstanding restricted stock unit (each, an "Unvested Company RSU") was cancelled and converted into the right to receive an amount in cash equal to the product obtained by multiplying (x) the total number of shares of the Company's common stock underlying such Unvested Company RSU, by (y) $176.00, in each case subject to the same vesting schedule, termination terms and other conditions as such Unvested Company RSU was subject to immediately prior to the Effective Time, subject to the holder's continued service with the Parent or its affiliates. F5 · derivative.exercise_date: Pursuant to the Merger Agreement, immediately prior to the Effective Time, each unvested and outstanding restricted stock unit (each, an "Unvested Company RSU") was cancelled and converted into the right to receive an amount in cash equal to the product obtained by multiplying (x) the total number of shares of the Company's common stock underlying such Unvested Company RSU, by (y) $176.00, in each case subject to the same vesting schedule, termination terms and other conditions as such Unvested Company RSU was subject to immediately prior to the Effective Time, subject to the holder's continued service with the Parent or its affiliates. F6 · derivative.expiration_date: Restricted stock units do not expire; they either vest or are canceled prior to vesting date. Read SEC document
August 31, 2021 Filed Aug 31, 2021 18:02 UTC	PROOFPOINT INC PFPT · Entity 135877	Disposition to issuerRestricted Stock Units · Derivative	8,000	Not disclosed Strike: $0.00	Not disclosed	Disclosure SEC source: 0001209191-21-054026 · doc4.xml · derivative · entry 8 Auvil Paul R. III · CIK 0001410972 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,000 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's common stock upon settlement for no consideration. F5 · kind: Pursuant to the Merger Agreement, immediately prior to the Effective Time, each unvested and outstanding restricted stock unit (each, an "Unvested Company RSU") was cancelled and converted into the right to receive an amount in cash equal to the product obtained by multiplying (x) the total number of shares of the Company's common stock underlying such Unvested Company RSU, by (y) $176.00, in each case subject to the same vesting schedule, termination terms and other conditions as such Unvested Company RSU was subject to immediately prior to the Effective Time, subject to the holder's continued service with the Parent or its affiliates. F5 · price: Pursuant to the Merger Agreement, immediately prior to the Effective Time, each unvested and outstanding restricted stock unit (each, an "Unvested Company RSU") was cancelled and converted into the right to receive an amount in cash equal to the product obtained by multiplying (x) the total number of shares of the Company's common stock underlying such Unvested Company RSU, by (y) $176.00, in each case subject to the same vesting schedule, termination terms and other conditions as such Unvested Company RSU was subject to immediately prior to the Effective Time, subject to the holder's continued service with the Parent or its affiliates. F5 · derivative.exercise_date: Pursuant to the Merger Agreement, immediately prior to the Effective Time, each unvested and outstanding restricted stock unit (each, an "Unvested Company RSU") was cancelled and converted into the right to receive an amount in cash equal to the product obtained by multiplying (x) the total number of shares of the Company's common stock underlying such Unvested Company RSU, by (y) $176.00, in each case subject to the same vesting schedule, termination terms and other conditions as such Unvested Company RSU was subject to immediately prior to the Effective Time, subject to the holder's continued service with the Parent or its affiliates. F6 · derivative.expiration_date: Restricted stock units do not expire; they either vest or are canceled prior to vesting date. Read SEC document
August 31, 2021 Filed Aug 31, 2021 18:02 UTC	PROOFPOINT INC PFPT · Entity 135877	Disposition to issuerRestricted Stock Units · Derivative	12,500	Not disclosed Strike: $0.00	Not disclosed	Disclosure SEC source: 0001209191-21-054026 · doc4.xml · derivative · entry 7 Auvil Paul R. III · CIK 0001410972 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,500 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's common stock upon settlement for no consideration. F5 · kind: Pursuant to the Merger Agreement, immediately prior to the Effective Time, each unvested and outstanding restricted stock unit (each, an "Unvested Company RSU") was cancelled and converted into the right to receive an amount in cash equal to the product obtained by multiplying (x) the total number of shares of the Company's common stock underlying such Unvested Company RSU, by (y) $176.00, in each case subject to the same vesting schedule, termination terms and other conditions as such Unvested Company RSU was subject to immediately prior to the Effective Time, subject to the holder's continued service with the Parent or its affiliates. F5 · price: Pursuant to the Merger Agreement, immediately prior to the Effective Time, each unvested and outstanding restricted stock unit (each, an "Unvested Company RSU") was cancelled and converted into the right to receive an amount in cash equal to the product obtained by multiplying (x) the total number of shares of the Company's common stock underlying such Unvested Company RSU, by (y) $176.00, in each case subject to the same vesting schedule, termination terms and other conditions as such Unvested Company RSU was subject to immediately prior to the Effective Time, subject to the holder's continued service with the Parent or its affiliates. F5 · derivative.exercise_date: Pursuant to the Merger Agreement, immediately prior to the Effective Time, each unvested and outstanding restricted stock unit (each, an "Unvested Company RSU") was cancelled and converted into the right to receive an amount in cash equal to the product obtained by multiplying (x) the total number of shares of the Company's common stock underlying such Unvested Company RSU, by (y) $176.00, in each case subject to the same vesting schedule, termination terms and other conditions as such Unvested Company RSU was subject to immediately prior to the Effective Time, subject to the holder's continued service with the Parent or its affiliates. F6 · derivative.expiration_date: Restricted stock units do not expire; they either vest or are canceled prior to vesting date. Read SEC document
August 31, 2021 Filed Aug 31, 2021 18:02 UTC	PROOFPOINT INC PFPT · Entity 135877	Disposition to issuerRestricted Stock Units · Derivative	4,150	Not disclosed Strike: $0.00	Not disclosed	Disclosure SEC source: 0001209191-21-054026 · doc4.xml · derivative · entry 6 Auvil Paul R. III · CIK 0001410972 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,150 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's common stock upon settlement for no consideration. F5 · kind: Pursuant to the Merger Agreement, immediately prior to the Effective Time, each unvested and outstanding restricted stock unit (each, an "Unvested Company RSU") was cancelled and converted into the right to receive an amount in cash equal to the product obtained by multiplying (x) the total number of shares of the Company's common stock underlying such Unvested Company RSU, by (y) $176.00, in each case subject to the same vesting schedule, termination terms and other conditions as such Unvested Company RSU was subject to immediately prior to the Effective Time, subject to the holder's continued service with the Parent or its affiliates. F5 · price: Pursuant to the Merger Agreement, immediately prior to the Effective Time, each unvested and outstanding restricted stock unit (each, an "Unvested Company RSU") was cancelled and converted into the right to receive an amount in cash equal to the product obtained by multiplying (x) the total number of shares of the Company's common stock underlying such Unvested Company RSU, by (y) $176.00, in each case subject to the same vesting schedule, termination terms and other conditions as such Unvested Company RSU was subject to immediately prior to the Effective Time, subject to the holder's continued service with the Parent or its affiliates. F5 · derivative.exercise_date: Pursuant to the Merger Agreement, immediately prior to the Effective Time, each unvested and outstanding restricted stock unit (each, an "Unvested Company RSU") was cancelled and converted into the right to receive an amount in cash equal to the product obtained by multiplying (x) the total number of shares of the Company's common stock underlying such Unvested Company RSU, by (y) $176.00, in each case subject to the same vesting schedule, termination terms and other conditions as such Unvested Company RSU was subject to immediately prior to the Effective Time, subject to the holder's continued service with the Parent or its affiliates. F6 · derivative.expiration_date: Restricted stock units do not expire; they either vest or are canceled prior to vesting date. Read SEC document
August 31, 2021 Filed Aug 31, 2021 18:02 UTC	PROOFPOINT INC PFPT · Entity 135877	Disposition to issuerNon-qualified Stock Option (right to buy) · Derivative	32,000	Not disclosed Strike: $50.93	Not disclosed	Disclosure SEC source: 0001209191-21-054026 · doc4.xml · derivative · entry 5 Auvil Paul R. III · CIK 0001410972 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 32,000 shares Expires 2026-04-08 F2 · kind: Pursuant to the Merger Agreement, at the Effective Time, each vested Company stock option was cancelled and converted into the right to receive an amount in cash equal to (i) the difference between $176.00 and the exercise price of such stock option multiplied by (ii) the number of shares subject to such stock option. F2 · price: Pursuant to the Merger Agreement, at the Effective Time, each vested Company stock option was cancelled and converted into the right to receive an amount in cash equal to (i) the difference between $176.00 and the exercise price of such stock option multiplied by (ii) the number of shares subject to such stock option. F2 · derivative.exercise_date: Pursuant to the Merger Agreement, at the Effective Time, each vested Company stock option was cancelled and converted into the right to receive an amount in cash equal to (i) the difference between $176.00 and the exercise price of such stock option multiplied by (ii) the number of shares subject to such stock option. F3 · derivative.exercise_date: The stock option is fully vested. Read SEC document
August 31, 2021 Filed Aug 31, 2021 18:02 UTC	PROOFPOINT INC PFPT · Entity 135877	Disposition to issuerNon-qualified Stock Option (right to buy) · Derivative	32,000	Not disclosed Strike: $57.49	Not disclosed	Disclosure SEC source: 0001209191-21-054026 · doc4.xml · derivative · entry 4 Auvil Paul R. III · CIK 0001410972 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 32,000 shares Expires 2025-04-06 F2 · kind: Pursuant to the Merger Agreement, at the Effective Time, each vested Company stock option was cancelled and converted into the right to receive an amount in cash equal to (i) the difference between $176.00 and the exercise price of such stock option multiplied by (ii) the number of shares subject to such stock option. F2 · price: Pursuant to the Merger Agreement, at the Effective Time, each vested Company stock option was cancelled and converted into the right to receive an amount in cash equal to (i) the difference between $176.00 and the exercise price of such stock option multiplied by (ii) the number of shares subject to such stock option. F2 · derivative.exercise_date: Pursuant to the Merger Agreement, at the Effective Time, each vested Company stock option was cancelled and converted into the right to receive an amount in cash equal to (i) the difference between $176.00 and the exercise price of such stock option multiplied by (ii) the number of shares subject to such stock option. F3 · derivative.exercise_date: The stock option is fully vested. Read SEC document
August 31, 2021 Filed Aug 31, 2021 18:02 UTC	PROOFPOINT INC PFPT · Entity 135877	Disposition to issuerNon-qualified Stock Option (right to buy) · Derivative	80,000	Not disclosed Strike: $36.00	Not disclosed	Disclosure SEC source: 0001209191-21-054026 · doc4.xml · derivative · entry 3 Auvil Paul R. III · CIK 0001410972 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 80,000 shares Expires 2024-03-26 F2 · kind: Pursuant to the Merger Agreement, at the Effective Time, each vested Company stock option was cancelled and converted into the right to receive an amount in cash equal to (i) the difference between $176.00 and the exercise price of such stock option multiplied by (ii) the number of shares subject to such stock option. F2 · price: Pursuant to the Merger Agreement, at the Effective Time, each vested Company stock option was cancelled and converted into the right to receive an amount in cash equal to (i) the difference between $176.00 and the exercise price of such stock option multiplied by (ii) the number of shares subject to such stock option. F2 · derivative.exercise_date: Pursuant to the Merger Agreement, at the Effective Time, each vested Company stock option was cancelled and converted into the right to receive an amount in cash equal to (i) the difference between $176.00 and the exercise price of such stock option multiplied by (ii) the number of shares subject to such stock option. F3 · derivative.exercise_date: The stock option is fully vested. Read SEC document
August 31, 2021 Filed Aug 31, 2021 18:02 UTC	PROOFPOINT INC PFPT · Entity 135877	Disposition to issuerCommon Stock	261,918	$176.00	$46,097,568.00	Disclosure SEC source: 0001209191-21-054026 · doc4.xml · nonDerivative · entry 2 Auvil Paul R. III · CIK 0001410972 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By family trust Disclosed balance after: 0 F1 · kind: On April 25, 2021, Proofpoint, Inc. (the "Company") entered into an Agreement and Plan of Merger (as it may be amended, supplemented or otherwise modified from time to time, the "Merger Agreement") with Project Kafka Parent, LLC ("Parent") and Project Kafka Merger Sub, Inc., a wholly-owned subsidiary of Parent ("Merger Sub"), pursuant to which Merger Sub was merged with and into the Company (the "Merger"), with the Company surviving the Merger as a wholly owned subsidiary of Parent. Pursuant to the Merger Agreement, all shares of Company common stock outstanding immediately prior to the effective time of the Merger (the "Effective Time"), were canceled and converted automatically into the right to receive $176.00 in cash. Read SEC document
August 31, 2021 Filed Aug 31, 2021 18:02 UTC	PROOFPOINT INC PFPT · Entity 135877	Disposition to issuerCommon Stock	122,063	$176.00	$21,483,088.00	Disclosure SEC source: 0001209191-21-054026 · doc4.xml · nonDerivative · entry 1 Auvil Paul R. III · CIK 0001410972 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: On April 25, 2021, Proofpoint, Inc. (the "Company") entered into an Agreement and Plan of Merger (as it may be amended, supplemented or otherwise modified from time to time, the "Merger Agreement") with Project Kafka Parent, LLC ("Parent") and Project Kafka Merger Sub, Inc., a wholly-owned subsidiary of Parent ("Merger Sub"), pursuant to which Merger Sub was merged with and into the Company (the "Merger"), with the Company surviving the Merger as a wholly owned subsidiary of Parent. Pursuant to the Merger Agreement, all shares of Company common stock outstanding immediately prior to the effective time of the Merger (the "Effective Time"), were canceled and converted automatically into the right to receive $176.00 in cash. Read SEC document
August 18, 2021 Filed Aug 19, 2021 21:21 UTC	PROOFPOINT INC PFPT · Entity 135877	GiftCommon Stock	30,000	$0.00	$0.00	Disclosure SEC source: 0001209191-21-052588 · doc4.xml · nonDerivative · entry 1 Auvil Paul R. III · CIK 0001410972 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By family trust Disclosed balance after: 231,918 Read SEC document
July 15, 2021 Filed Jul 19, 2021 22:49 UTC	1Life Healthcare Inc ONEM · Entity 116460	GrantCommon Stock	534	$0.00	$0.00	Disclosure SEC source: 0001562180-21-004989 · primarydocument.xml · nonDerivative · entry 1 Auvil Paul R. III · CIK 0001410972 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 534 F1 · shares: Represents restricted stock units granted to the reporting person pursuant to the Issuer's 2020 Equity Incentive Plan. The restricted stock units vested immediately on the date of grant. Read SEC document
June 03, 2021 Filed Jun 8, 2021 00:22 UTC	1Life Healthcare Inc ONEM · Entity 116460	GrantRestricted Stock Units · Derivative	4,534	$0.00	$0.00	Disclosure SEC source: 0001562180-21-004102 · primarydocument.xml · derivative · entry 1 Auvil Paul R. III · CIK 0001410972 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,534 Underlying: Common Stock · 4,534 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: The restricted stock units will vest on the earlier of (i) the date of the issuer's next annual meeting of stockholders (or the date immediately prior to the next annual meeting of stockholders if the reporting person's service as a director ends at such meeting due to the director's failure to be re-elected or the director not standing for re-election); or (ii) the one-year anniversary measured from the date of grant. F2 · derivative.expiration_date: The restricted stock units will vest on the earlier of (i) the date of the issuer's next annual meeting of stockholders (or the date immediately prior to the next annual meeting of stockholders if the reporting person's service as a director ends at such meeting due to the director's failure to be re-elected or the director not standing for re-election); or (ii) the one-year anniversary measured from the date of grant. Read SEC document
June 01, 2021 Filed Jun 2, 2021 20:48 UTC	PROOFPOINT INC PFPT · Entity 135877	Exercise / conversionRestricted Stock Units · Derivative	12,500	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001209191-21-037257 · doc4.xml · derivative · entry 4 Auvil Paul R. III · CIK 0001410972 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. F1 · kind: Vesting of restricted stock units ("RSUs") granted to the Reporting Person on June 8, 2018. F4 · derivative.exercise_date: The RSUs vest as to 1/4th of the total number of shares in equal annual installments beginning on June 1, 2019. Shares of the Issuer's common stock will be delivered to the Reporting Person following vesting. F5 · derivative.expiration_date: RSUs do not expire; they either vest or are canceled prior to vesting date. Read SEC document
June 01, 2021 Filed Jun 2, 2021 20:48 UTC	PROOFPOINT INC PFPT · Entity 135877	Tax withholdingCommon Stock	6,198	$172.96	$1,072,006.08	Disclosure SEC source: 0001209191-21-037257 · doc4.xml · nonDerivative · entry 2 Auvil Paul R. III · CIK 0001410972 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,063 F2 · kind: Exempt transaction pursuant to Section 16b-3(e) - payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. All of the shares reported as disposed of in this Form 4 were relinquished by the Reporting Person and cancelled by the Issuer in exchange for the Issuer's agreement to pay federal and state tax withholding obligations of the Reporting Person resulting from the vesting of RSUs. Read SEC document
June 01, 2021 Filed Jun 2, 2021 20:48 UTC	PROOFPOINT INC PFPT · Entity 135877	Exercise / conversionCommon Stock	12,500	$0.00	$0.00	Disclosure SEC source: 0001209191-21-037257 · doc4.xml · nonDerivative · entry 1 Auvil Paul R. III · CIK 0001410972 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,261 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Vesting of restricted stock units ("RSUs") granted to the Reporting Person on June 8, 2018. Read SEC document
April 20, 2021 Filed Apr 22, 2021 22:19 UTC	PROOFPOINT INC PFPT · Entity 135877	Exercise / conversionRestricted Stock Units · Derivative	938	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001209191-21-027988 · doc4.xml · derivative · entry 5 Auvil Paul R. III · CIK 0001410972 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,812 Underlying: Common Stock · 938 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. F4 · derivative.exercise_date: The RSUs vested as to 1/4 of the total number of shares subject to the award on April 20, 2021; an additional 1/4 of the total number of shares subject to the award will vest on each of January 1, 2022, January 1, 2023, and January 1, 2024, subject to the Reporting Person's continued service to the Issuer through such dates. Shares of the Issuer's common stock will be delivered to the Reporting Person following vesting. F5 · derivative.expiration_date: RSUs do not expire; they either vest or are canceled prior to vesting date. Read SEC document
April 20, 2021 Filed Apr 22, 2021 22:19 UTC	PROOFPOINT INC PFPT · Entity 135877	GrantRestricted Stock Units · Derivative	3,750	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001209191-21-027988 · doc4.xml · derivative · entry 4 Auvil Paul R. III · CIK 0001410972 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,750 Underlying: Common Stock · 3,750 shares Expires not disclosed F3 · derivative.exercise_price: Each RSU represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. F1 · kind: Vesting of restricted stock units ("RSUs") earned by the Reporting Person on April 20, 2021 as determined by the Issuer's Board of Directors. F4 · derivative.exercise_date: The RSUs vested as to 1/4 of the total number of shares subject to the award on April 20, 2021; an additional 1/4 of the total number of shares subject to the award will vest on each of January 1, 2022, January 1, 2023, and January 1, 2024, subject to the Reporting Person's continued service to the Issuer through such dates. Shares of the Issuer's common stock will be delivered to the Reporting Person following vesting. F5 · derivative.expiration_date: RSUs do not expire; they either vest or are canceled prior to vesting date. Read SEC document
April 20, 2021 Filed Apr 22, 2021 22:19 UTC	PROOFPOINT INC PFPT · Entity 135877	Tax withholdingCommon Stock	466	$130.01	$60,584.66	Disclosure SEC source: 0001209191-21-027988 · doc4.xml · nonDerivative · entry 2 Auvil Paul R. III · CIK 0001410972 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,761 F2 · kind: Exempt transaction pursuant to Section 16b-3(e) - payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. All of the shares reported as disposed of in this Form 4 were relinquished by the Reporting Person and cancelled by the Issuer in exchange for the Issuer's agreement to pay federal and state tax withholding obligations of the Reporting Person resulting from the vesting of RSUs. Read SEC document
April 20, 2021 Filed Apr 22, 2021 22:19 UTC	PROOFPOINT INC PFPT · Entity 135877	Exercise / conversionCommon Stock	938	$0.00	$0.00	Disclosure SEC source: 0001209191-21-027988 · doc4.xml · nonDerivative · entry 1 Auvil Paul R. III · CIK 0001410972 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,227 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Vesting of restricted stock units ("RSUs") earned by the Reporting Person on April 20, 2021 as determined by the Issuer's Board of Directors. Read SEC document
April 15, 2021 Filed Apr 19, 2021 22:03 UTC	1Life Healthcare Inc ONEM · Entity 116460	GrantStock Option (Right to Buy) · Derivative	718	$0.00 Strike: $42.70	$0.00	Disclosure SEC source: 0001562180-21-002862 · primarydocument.xml · derivative · entry 1 Auvil Paul R. III · CIK 0001410972 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 718 Underlying: Common Stock · 718 shares Expires 2031-04-14 Read SEC document
March 05, 2021 Filed Mar 9, 2021 21:36 UTC	PROOFPOINT INC PFPT · Entity 135877	GrantRestricted Stock Units · Derivative	40,000	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001209191-21-019019 · doc4.xml · derivative · entry 1 Auvil Paul R. III · CIK 0001410972 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. F2 · derivative.exercise_date: The RSUs vest as to 1/4th of the total award in equal annual installments, with the first 1/4th vesting on February 1, 2022. Shares of the Issuer's Common Stock will be delivered to the Reporting Person following vesting. F3 · derivative.expiration_date: RSUs do not expire; they either vest or are canceled prior to vesting date. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.